EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway

Yingxu Shi iD, Yu Tang, Zhiwei Sun, Ping Sui, Yiming Shao, Zhonghao Wang, Jian Zhang, Ming Gao

Drug Design, Development and Therapy · 2025-01 · Volume 19 · 51-64

DOI: 10.2147/dddt.s489092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-01. Verfasst von Yingxu Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma Orthopedics, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272007, People's Republic of China. Hauptthemen laut MEDLINE: Osteosarcoma, Toll-Like Receptor 4, TNF Receptor-Associated Factor 6, NF-kappa B. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaToll-Like Receptor 4TNF Receptor-Associated Factor 6NF-kappa BBone NeoplasmsAntineoplastic AgentsAntineoplastic Agents, PhytogenicHumansCell ProliferationMiceAnimalsSignal TransductionDrug Screening Assays, AntitumorDose-Response Relationship, DrugMolecular Docking SimulationTumor Cells, CulturedMice, NudeStructure-Activity RelationshipNeoplasms, ExperimentalIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

NF-κB pathwayTLR4molecular modelingosteosarcomascutellarein

Substanzen

Toll-Like Receptor 4TNF Receptor-Associated Factor 6NF-kappa BTLR4 protein, humanAntineoplastic AgentsTifab protein, humanAntineoplastic Agents, PhytogenicIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Trauma Orthopedics, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272007, People's Republic of China.
  • Pharmaceutical Department, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272007, People's Republic of China.
  • Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
  • Department of Clinical Medicine, Jining Medical University, Jining, Shandong, 272067, People's Republic of China.

ORCID-Profile: Yingxu Shi

Zitieren

APA

Shi, Y., Tang, Y., Sun, Z., Sui, P., Shao, Y., Wang, Z., Zhang, J., & Gao, M. (2025). Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway. Drug Design, Development and Therapy, Volume 19, 51-64. https://doi.org/10.2147/dddt.s489092

Vancouver

Shi Y, Tang Y, Sun Z, Sui P, Shao Y, Wang Z, et al. Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway. Drug Design, Development and Therapy. 2025;Volume 19:51-64. doi:10.2147/dddt.s489092

BibTeX
@article{Shi2025,
  author = {Shi, Yingxu and Tang, Yu and Sun, Zhiwei and Sui, Ping and Shao, Yiming and Wang, Zhonghao and Zhang, Jian and Gao, Ming},
  title = {Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {51--64},
  doi = {10.2147/dddt.s489092}
}
Kostenlos starten →